SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Elicera Therapeutics Receives Positive Patent Notice for ELC-401 in China

Elicera Therapeutics says it has received a positive patent notice for ELC-401 in China.

Related stories